TP53 and neoplasm: In a translational substudy, sequencing of sequential circulating cell-free tumor DNA demonstrated that increases in burden of radiologically apparent disease correlated with increasing levels of peripherally detectable TP53 mutation.56 These data implicate clonal outgrowth of TP53-mutated tumor as a potential mechanism of resistance to MDM2 inhibition.